Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Berlex now marketing Levulan Kerastick photodynamic therapy in U.S.

Dec. 13, 2000

No Comments

FDA approves Protopic for the treatment of eczema

Dec. 11, 2000

No Comments

NicOx's HCT-1026 shows promise for treatment of skin inflammation

Nov. 29, 2000

No Comments

Dusa moves Levulan into phase I/II for the treatment of acne

Nov. 29, 2000

No Comments

Phytopharm begins phase II trial of P-45 for alopecia areata

Nov. 28, 2000

No Comments

Angiotech begins phase II trial with micellar paclitaxel for psoriasis

Nov. 27, 2000

No Comments

Licensing opportunity from NIH: smad3 protein inhibition to enhance wound healing

Nov. 20, 2000

No Comments

Steroid-free eczema treatment recommended for FDA approval

Nov. 17, 2000

No Comments

Cellegy seeks approval of Rectogesic in New Zealand

Nov. 15, 2000

No Comments

MBI-594AN advances to phase II for treatment of acne

Nov. 10, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Dermatologic
RSS

Berlex now marketing Levulan Kerastick photodynamic therapy in U.S.

FDA approves Protopic for the treatment of eczema

NicOx's HCT-1026 shows promise for treatment of skin inflammation

Dusa moves Levulan into phase I/II for the treatment of acne

Phytopharm begins phase II trial of P-45 for alopecia areata

Angiotech begins phase II trial with micellar paclitaxel for psoriasis

Licensing opportunity from NIH: smad3 protein inhibition to enhance wound healing

Steroid-free eczema treatment recommended for FDA approval

Cellegy seeks approval of Rectogesic in New Zealand

MBI-594AN advances to phase II for treatment of acne

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Dermatologic RSS

Dermatologic
RSS